Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines

Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?

Yang, Hayang
Bouma, Berto J.
Mulder, Barbara J. M.

January 2017

In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly p...

Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?

Yang, Hayang
Bouma, Berto J.
Mulder, Barbara J. M.

January 2017

In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly p...

Once atrial fibrillation, always oral anticoagulation?

Verheugt, F.W.A.

January 2007

Contains fulltext : 53358.pdf (publisher's version ) (Closed access

Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines

Yang, H.
Heidendael, J. F.
de Groot, J. R.
Konings, T. C.
Veen, G.
van Dijk, A. P.J.
Meijboom, F. J.
Sieswerda, G. Tj
Post, M. C.
Winter, M. M.
Mulder, B. J.M.
Bouma, B. J.

April 2018

Background: Current guidelines on oral anticoagulation (OAC) in adults with congenital heart disease...

Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias : Implementation of guidelines

Yang, H.
Heidendael, J. F.
de Groot, J. R.
Konings, T. C.
Veen, G.
van Dijk, A. P.J.
Meijboom, F. J.
Sieswerda, G. Tj
Post, M. C.
Winter, M. M.
Mulder, B. J.M.
Bouma, B. J.

April 2018

Background: Current guidelines on oral anticoagulation (OAC) in adults with congenital heart disease...

Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines

Yang, H.
Heidendael, J. F.
de Groot, J. R.
Konings, T. C.
Veen, G.
van Dijk, A. P. J.
Meijboom, F. J.
Sieswerda, G. Tj.
Post, M. C.
Winter, M. M.
Mulder, B. J. M.
Bouma, B. J.

January 2018

Background: Current guidelines on oral anticoagulation (OAC) in adults with congenital heart disease...

Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias : Implementation of guidelines

Yang, H.
Heidendael, J. F.
de Groot, J. R.
Konings, T. C.
Veen, G.
van Dijk, A. P.J.
Meijboom, F. J.
Sieswerda, G. Tj
Post, M. C.
Winter, M. M.
Mulder, B. J.M.
Bouma, B. J.

April 2018

Background: Current guidelines on oral anticoagulation (OAC) in adults with congenital heart disease...

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.

Rubboli, A.
Halperin, J.L.
Juhani Airaksinen, K.E.
Buerke, M.
Eeckhout, E.
Freedman, S.B.
Gershlick, A.H.
Schlitt, A.
Fat Tse, H.
Verheugt, F.W.A.
Lip, G.Y.

January 2008

Contains fulltext : 69849.pdf (Publisher’s version ) (Closed access

Oral anticoagulant therapy in percutaneous coronary intervention

Berg, J.M. ten

January 2001

Contains fulltext : 146838.pdf (Publisher’s version ) (Open Access)171 p

Anticoagulation in patients with mechanical heart valves: follow the guidelines!

Verheugt, F.W.A.

January 2015

Contains fulltext : 154411.pdf (publisher's version ) (Open Access

Correspondence to

Royal Brompton
National Heart
Dr Annette Schophuus Jensen

January 2014

Adults with congenital heart disease are a growing population. One of the major challenges in the ca...

Correspondence to

Royal Brompton
National Heart
Dr Annette Schophuus Jensen
Nørager B
Et Al. Heart

January 2014

[please include Day Month Year] doi:10.1136/heartjnl-2014-305576 Adults with congenital heart diseas...

Anticoagulants in heart disease: current status and perspectives.

Caterina, R. de
Husted, S.
Wallentin, L.
Agnelli, G.
Bachmann, F.
Baigent, C.
Jespersen, J.
Kristensen, S.D.
Montalescot, G.
Siegbahn, A.
Verheugt, F.W.A.
Weitz, J.

January 2007

Contains fulltext : 52834.pdf (publisher's version ) (Closed access

Oral anticoagulants before and after ablation for atrial fibrillation.

Verheugt, F.W.A.
Khan, M.
Ruiter, G.S. De
Riezebos, R.K.

January 2010

Contains fulltext : 89926.pdf (publisher's version ) (Closed access)1 juli 201

Novel oral anticoagulant use in adults with congenital heart disease : a single-center experience report

Samarai, Daniel
Isma, Nazim
Lindstedt, Sandra
Hlebowicz, Joanna

December 2023

Background: Adults with congenital heart disease (ACHD) are a group with an increased risk of thromb...

Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?

Yang, Hayang
Bouma, Berto J.
Mulder, Barbara J. M.

January 2017

In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly p...

Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?

Yang, Hayang
Bouma, Berto J.
Mulder, Barbara J. M.

January 2017

In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly p...

Once atrial fibrillation, always oral anticoagulation?

Verheugt, F.W.A.

January 2007

Contains fulltext : 53358.pdf (publisher's version ) (Closed access

Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines

Yang, H.
Heidendael, J. F.
de Groot, J. R.
Konings, T. C.
Veen, G.
van Dijk, A. P.J.
Meijboom, F. J.
Sieswerda, G. Tj
Post, M. C.
Winter, M. M.
Mulder, B. J.M.
Bouma, B. J.

April 2018

Background: Current guidelines on oral anticoagulation (OAC) in adults with congenital heart disease...

Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias : Implementation of guidelines

Yang, H.
Heidendael, J. F.
de Groot, J. R.
Konings, T. C.
Veen, G.
van Dijk, A. P.J.
Meijboom, F. J.
Sieswerda, G. Tj
Post, M. C.
Winter, M. M.
Mulder, B. J.M.
Bouma, B. J.

April 2018

Background: Current guidelines on oral anticoagulation (OAC) in adults with congenital heart disease...

Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines

Yang, H.
Heidendael, J. F.
de Groot, J. R.
Konings, T. C.
Veen, G.
van Dijk, A. P. J.
Meijboom, F. J.
Sieswerda, G. Tj.
Post, M. C.
Winter, M. M.
Mulder, B. J. M.
Bouma, B. J.

January 2018

Background: Current guidelines on oral anticoagulation (OAC) in adults with congenital heart disease...

Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias : Implementation of guidelines

Yang, H.
Heidendael, J. F.
de Groot, J. R.
Konings, T. C.
Veen, G.
van Dijk, A. P.J.
Meijboom, F. J.
Sieswerda, G. Tj
Post, M. C.
Winter, M. M.
Mulder, B. J.M.
Bouma, B. J.

April 2018

Background: Current guidelines on oral anticoagulation (OAC) in adults with congenital heart disease...

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.

Rubboli, A.
Halperin, J.L.
Juhani Airaksinen, K.E.
Buerke, M.
Eeckhout, E.
Freedman, S.B.
Gershlick, A.H.
Schlitt, A.
Fat Tse, H.
Verheugt, F.W.A.
Lip, G.Y.

January 2008

Contains fulltext : 69849.pdf (Publisher’s version ) (Closed access

Oral anticoagulant therapy in percutaneous coronary intervention

Berg, J.M. ten

January 2001

Contains fulltext : 146838.pdf (Publisher’s version ) (Open Access)171 p

Anticoagulation in patients with mechanical heart valves: follow the guidelines!

Verheugt, F.W.A.

January 2015

Contains fulltext : 154411.pdf (publisher's version ) (Open Access

Correspondence to

Royal Brompton
National Heart
Dr Annette Schophuus Jensen

January 2014

Adults with congenital heart disease are a growing population. One of the major challenges in the ca...

Correspondence to

Royal Brompton
National Heart
Dr Annette Schophuus Jensen
Nørager B
Et Al. Heart

January 2014

[please include Day Month Year] doi:10.1136/heartjnl-2014-305576 Adults with congenital heart diseas...

Anticoagulants in heart disease: current status and perspectives.

Caterina, R. de
Husted, S.
Wallentin, L.
Agnelli, G.
Bachmann, F.
Baigent, C.
Jespersen, J.
Kristensen, S.D.
Montalescot, G.
Siegbahn, A.
Verheugt, F.W.A.
Weitz, J.

January 2007

Contains fulltext : 52834.pdf (publisher's version ) (Closed access

Oral anticoagulants before and after ablation for atrial fibrillation.

Verheugt, F.W.A.
Khan, M.
Ruiter, G.S. De
Riezebos, R.K.

January 2010

Contains fulltext : 89926.pdf (publisher's version ) (Closed access)1 juli 201

Novel oral anticoagulant use in adults with congenital heart disease : a single-center experience report

Samarai, Daniel
Isma, Nazim
Lindstedt, Sandra
Hlebowicz, Joanna

December 2023

Background: Adults with congenital heart disease (ACHD) are a group with an increased risk of thromb...

Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?

Yang, Hayang
Bouma, Berto J.
Mulder, Barbara J. M.

January 2017

In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly p...

Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?

Yang, Hayang
Bouma, Berto J.
Mulder, Barbara J. M.

January 2017

In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly p...

Once atrial fibrillation, always oral anticoagulation?

Verheugt, F.W.A.

January 2007

Contains fulltext : 53358.pdf (publisher's version ) (Closed access

Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines

Abstract

Extracted data

Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines

Abstract

Extracted data

Related items

Related items